Integration of amyloid-β oligomerization tendency as a plasma biomarker in Alzheimer's disease diagnosis

Integration of amyloid-β oligomerization tendency as a plasma biomarker in Alzheimer's disease diagnosis

IntroductionThere has been significant development in blood-based biomarkers targeting amyloidopathy of Alzheimer's disease (AD). However, the guidelines for integrating such biomarkers into AD diagnosis are still inadequate. Multimer Detection System-Oligomeric Amyloid-β (MDS-OAβ) as a plasma...

Full description

Bibliographic Details
Main Authors:	Jung-Min Pyun, Young Chul Youn, Young Ho Park, SangYun Kim
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Neurology
Subjects:	Alzheimer's disease blood-based biomarker amyloid-β oligomerization tendency diagnosis neuropsychological test
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2022.1028448/full

Similar Items

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease
by: Young Chul Youn, et al.
Published: (2019-05-01)

Plasma Amyloid-β Oligomerization Tendency Predicts Amyloid PET Positivity
by: Pyun JM, et al.
Published: (2021-04-01)

Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease
by: Min Jeong Wang, et al.
Published: (2017-12-01)

Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ42
by: Seong Soo A. An, et al.
Published: (2017-10-01)

Characterization of the selective in vitro and in vivo binding properties of crenezumab to oligomeric Aβ
by: William J. Meilandt, et al.
Published: (2019-12-01)

Differential effects of oligomeric and fibrillar amyloid-β1–42 on astrocyte-mediated inflammation
by: Jill A. White, et al.
Published: (2005-04-01)

Elevated Plasma Oligomeric Amyloid β-42 Is Associated with Cognitive Impairments in Cerebral Small Vessel Disease
by: Wensheng Qu, et al.
Published: (2023-01-01)

Prediction of amyloid PET positivity via machine learning algorithms trained with EDTA-based blood amyloid-β oligomerization data
by: Young Chul Youn, et al.
Published: (2022-11-01)

Structural Studies Providing Insights into Production and Conformational Behavior of Amyloid-β Peptide Associated with Alzheimer’s Disease Development
by: Anatoly S. Urban, et al.
Published: (2021-05-01)

Aβ42 fibril formation from predominantly oligomeric samples suggests a link between oligomer heterogeneity and fibril polymorphism
by: Christine Xue, et al.
Published: (2019-07-01)

Evidence for a Strong Relationship between the Cytotoxicity and Intracellular Location of β-Amyloid
by: Md. Aminul Haque, et al.
Published: (2022-04-01)

Oligomerization and Conformational Change Turn Monomeric β-Amyloid and Tau Proteins Toxic: Their Role in Alzheimer’s Pathogenesis
by: Botond Penke, et al.
Published: (2020-04-01)

Midazolam alleviates cellular senescence in SH‐SY5Y neuronal cells in Alzheimer's disease
by: Ping Wang, et al.
Published: (2023-01-01)

Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals
by: Noelia Fandos, et al.
Published: (2017-01-01)

Plasma amyloid-β oligomerization assay as a pre-screening test for amyloid status
by: Rosha Babapour Mofrad, et al.
Published: (2021-07-01)

Effects of α-Lipoic Acid on Phagocytosis of Oligomeric Beta-Amyloid1–42 in BV-2 Mouse Microglial Cells
by: Chih-Yuan Ko, et al.
Published: (2022-01-01)

5-Hydroxycyclopenicillone Inhibits β-Amyloid Oligomerization and Produces Anti-β-Amyloid Neuroprotective Effects In Vitro
by: Jiaying Zhao, et al.
Published: (2017-10-01)

β-amyloid oligomers in aging and Alzheimer's disease
by: Kathleen R. Zahs, et al.
Published: (2013-07-01)

Inhibition of Aβ42 oligomerization in yeast by a PICALM ortholog and certain FDA approved drugs
by: Sei-Kyoung Park, et al.
Published: (2016-01-01)

Plasma oligomer beta-amyloid is associated with disease severity and cerebral amyloid deposition in Alzheimer’s disease spectrum
by: Sheng-Min Wang, et al.
Published: (2024-03-01)

Vaccination against β-Amyloid as a Strategy for the Prevention of Alzheimer’s Disease
by: Francesca Mantile, et al.
Published: (2020-11-01)

Different aspects of Alzheimer’s disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia
by: Dietmar Rudolf Thal, et al.
Published: (2019-11-01)

β-Amyloids and Immune Responses Associated with Alzheimer’s Disease
by: Elizaveta Kolobova, et al.
Published: (2024-09-01)

Oligomeric amyloid-β targeted contrast agent for MRI evaluation of Alzheimer’s disease mouse models
by: Jang Woo Park, et al.
Published: (2024-06-01)

β-Amyloid: The Key Peptide in the Pathogenesis of Alzheimer’s Disease
by: Xiaojuan eSun, et al.
Published: (2015-09-01)

Discordant Amyloid Status Diagnosis in Alzheimer’s Disease
by: Lorena García-Vallés, et al.
Published: (2022-11-01)

Association of plasma amyloid-β oligomerization with theta/beta ratio in older adults
by: Heewon Bae, et al.
Published: (2023-12-01)

Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer’s disease polygenic risk score
by: Jori Tomassen, et al.
Published: (2022-12-01)

Collagenous Alzheimer amyloid plaque component impacts on the compaction of amyloid-β plaques
by: Tadafumi Hashimoto, et al.
Published: (2020-12-01)

Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer’s disease
by: Kyu Hwan Shim, et al.
Published: (2022-12-01)

Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer’s disease
by: Min Seok Baek, et al.
Published: (2020-10-01)

Anti-amyloid β hydrophobic peptides in Alzheimer’s disease: biomarkers and therapeutic potential
by: Carlos Gutierrez-Merino
Published: (2025-02-01)

Amyloid β and free heme: bloody new insights into the pathogenesis of Alzheimer’s disease
by: Jörg Flemmig, et al.
Published: (2018-01-01)

β-Asarone Inhibits Amyloid-β by Promoting Autophagy in a Cell Model of Alzheimer's Disease
by: Nanbu Wang, et al.
Published: (2020-01-01)

CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease
by: Adla Boumenir, et al.
Published: (2019-03-01)

Interplay of Energetics and ER Stress Exacerbates Alzheimer's Amyloid-β (Aβ) Toxicity in Yeast
by: Xin Chen, et al.
Published: (2017-07-01)

N-terminally truncated Aβ4-x proteoforms and their relevance for Alzheimer’s pathophysiology
by: Agueda Rostagno, et al.
Published: (2022-06-01)

β2‐microglobulin: An essential coaggregation factor with β‐amyloid in amyloid pathology
by: Chongyun Wu, et al.
Published: (2023-12-01)

Amyloid-β, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative Data
by: Isabelle Bos, et al.
Published: (2018-06-01)

Pathways to Alzheimer’s Disease: The Intersecting Roles of Clusterin and Apolipoprotein E in Amyloid-β Regulation and Neuronal Health
by: Alexandru Laslo, et al.
Published: (2024-10-01)